Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

ID: 595619

(firmenpresse) - SINGAPORE, July 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

The Partnership formalizes a long-standing working relationship between the two, enabling closer collaboration to ensure the high priority start-up of new projects, and cooperation in clinical trial promotion, business development, networking opportunities, clinical operation, training, and feasibility assessment.

SRIS was established as a collaboration between Agency for Science, Technology and Research (A*STAR), National Healthcare Group (NHG) and Nanyang Technological University (NTU) to conduct high impact, inter-disciplinary skin research that would translate into improved health outcomes and quality of life.

Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.

Novotech CEO Dr John Moller said the Partnership with SRIS will support the increasing demand from biotech clients for skin disorder studies in the Asia-Pacific region.

Please visit the Skin Research Institute of Singapore (SRIS)at https://www.a-star.edu.sg/sris/About-SRIS.

About Novotech:
Headquartered in Sydney, Novotech CRO is the internationally recognized Asia Pacific contract research organization (CRO) instrumental in hundreds of clinical trials across the region. https://novotech-cro.com/welcome
Check if Asia Pacific is right for your next study: https://novotechcro.typeform.com/to/Uwizka
For RFP enquiries, please fill out the form available at www.novotech-cro.com/contact-us-0





Media contact:
communications(at)novotech-cro.com
Susan Fitzpatrick-Napier
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427

Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  EU Healthcare Systems: a Reallocation Of Resources Is Urgently Needed Für den Hyaluronsäure-Viskosupplementierungsmarkt wird ein Wachstum von 6,36% im Prognosezeitraum prognostiziert, um einen Umsatz von 2948,78 Mio. USD bis 2023 zu erreichenc
Bereitgestellt von Benutzer: acnnewswire
Datum: 11.07.2019 - 10:23 Uhr
Sprache: Deutsch
News-ID 595619
Anzahl Zeichen: 2251

contact information:
Town:

SINGAPORE



Kategorie:

Healthcare & Medical


Typ of Press Release: Cooperation
type of sending: don't

Diese Pressemitteilung wurde bisher 201 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research"
steht unter der journalistisch-redaktionellen Verantwortung von

Novotech (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Novotech



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z